SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-8.57%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$181M
AUM Growth
+$181M
(-23%)
Cap. Flow
-$27.9M
Cap. Flow
% of AUM
-15.43%
Top 10 Holdings %
Top 10 Hldgs %
48.21%
Holding
48
New
12
Increased
6
Reduced
16
Closed
9
Top Buys
| 1 |
UnitedHealth
UNH
|
$6.32M |
| 2 |
Waters Corp
WAT
|
$5.19M |
| 3 |
Agilent Technologies
A
|
$4.7M |
| 4 |
AbbVie
ABBV
|
$4.44M |
| 5 |
Bristol-Myers Squibb
BMY
|
$3.96M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$9.01M |
| 2 |
Intuitive Surgical
ISRG
|
$8.6M |
| 3 |
Becton Dickinson
BDX
|
$6.03M |
| 4 |
Baxter International
BAX
|
$5.7M |
| 5 |
Medtronic
MDT
|
$5.4M |
Sector Composition
| 1 | Healthcare | 90.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bio-Rad Laboratories Class A
BIO
$8.06B
| $3.29M | 1.73% |
+10,000
| New | +$3.29M |
|
27
Smith & Nephew
SNN
$16.3B
| $3.07M | 1.62% |
125,000
-15,000
| -11% | -$369K |
|
28
Select Medical
SEM
$1.61B
| $2.83M | 1.49% |
150,000
+10,000
| +7% | +$189K |
|
29
Zoetis
ZTS
$69.3B
| $2.44M | 1.29% |
+15,000
| New | +$2.44M |
|
30
Zimmer Biomet
ZBH
$21B
| $2.11M | 1.11% |
20,000
-20,000
| -50% | -$2.11M |
|
31
Acadia Healthcare
ACHC
$2.12B
| $1.98M | 1.04% |
50,000
-65,000
| -57% | -$2.58M |
|
32
BioNTech
BNTX
$24B
| $1.71M | 0.9% |
+15,000
| New | +$1.71M |
|
33
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.65M | 0.87% |
+7,000
| New | +$1.65M |
|
34
Repligen
RGEN
$6.88B
| $1.44M | 0.76% |
10,000
-15,000
| -60% | -$2.16M |
|
35
Sarepta Therapeutics
SRPT
$1.78B
| $1.22M | 0.64% |
+10,000
| New | +$1.22M |
|
36
Maravai LifeSciences
MRVI
$350M
| $763K | 0.4% |
140,000
-285,000
| -67% | -$1.55M |
|
37
Ascendis Pharma
ASND
$11.8B
| – | – |
-10,000
| Closed | -$1.49M |
|
|
38
Baxter International
BAX
$12.7B
| – | – |
-150,000
| Closed | -$5.7M |
|
|
39
Becton Dickinson
BDX
$55.3B
| – | – |
-25,000
| Closed | -$6.03M |
|
|
40
Intuitive Surgical
ISRG
$170B
| – | – |
-17,500
| Closed | -$8.6M |
|
41
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – |
0
| – | – |
|
|
42
Medtronic
MDT
$119B
| – | – |
-60,000
| Closed | -$5.4M |
|
43
Revvity
RVTY
$10.5B
| – | – |
-40,000
| Closed | -$5.11M |
|
44
Stevanato
STVN
$6.28B
| – | – |
-140,000
| Closed | -$2.8M |
|
45
Teva Pharmaceuticals
TEVA
$21.1B
| – | – |
-170,000
| Closed | -$3.06M |
|
46
West Pharmaceutical
WST
$17.8B
| – | – |
-17,000
| Closed | -$5.1M |
|